# Axogen Corporation (NASDAQ: AXGN), Burleson, TX – FDA Inspections

Source: https://www.keypedia.com/companies/axogen-corporation/c1a3a1ba-57e3-4747-b670-8018198f0309

> Inspection records and compliance data for Axogen Corporation in Burleson, Texas. 5 FDA inspections on record, 1 Form 483, last inspected January 08, 2026. Publicly traded as NASDAQ: AXGN.

---

## Details

- Name: Axogen Corporation
- FEI Number: 3011006318
- Address Line 1: 300 Boone Rd Ste A3
- City: Burleson
- State: Texas
- Zip Code: 76028
- Country Name: United States
- Address: 300 Boone Rd Ste A3, Burleson, Texas 76028, United States
- Country: United States

## Stock

- Stock ticker: AXGN
- Exchange: NASDAQ
- Share price: $55.40
- Market cap: $3.3B
- Price as of: November 13, 2026

## Related Documents

- FDA Inspection 1298590 - Axogen Corporation - 2026-01-08 — source: FDA, date: January 8, 2026
- FDA Inspection 1298590 - Axogen Corporation - 2026-01-08 — classification: No Action Indicated (NAI), source: FDA, date: January 8, 2026
- [FDA Inspection 1275112 - Axogen Corporation - 2025-06-19](https://www.keypedia.com/records/fda_inspections/axogen-corporation/f4ae9eb6-cb40-4c95-b2cc-c695779c02b9) — source: FDA, date: June 19, 2025
- FDA Inspection 1177562 - Axogen Corporation - 2022-07-28 — classification: No Action Indicated (NAI), source: FDA, date: July 28, 2022
- FDA Inspection 1177562 - Axogen Corporation - 2022-07-28 — classification: No Action Indicated (NAI), source: FDA, date: July 28, 2022
- [EIR - Axogen Corporation - 2018-11-20](https://www.keypedia.com/records/eir/axogen-corporation/c5fdad80-03af-45d9-9dd0-7d2517fada2b) — source: FDA, date: November 20, 2018
- [FDA Inspection 1072238 - Axogen Corporation - 2018-11-20](https://www.keypedia.com/records/fda_inspections/axogen-corporation/6c574dbc-677c-4b2f-ae65-d7b0959d53d0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 20, 2018
- FDA Inspection 946545 - Axogen Corporation - 2015-10-13 — classification: No Action Indicated (NAI), source: FDA, date: October 13, 2015

## Related Companies

- [Musculoskeletal Transplant Foundation, Inc.](https://www.keypedia.com/companies/musculoskeletal-transplant-foundation-inc/2efe7215-a199-4614-9050-316e74697aa8)
- [NuVasive, Inc](https://www.keypedia.com/companies/nuvasive-inc/7d31c043-5e73-4ebf-b4c3-d1dcfa8306a4)
- [Micro Typing Systems, Inc.](https://www.keypedia.com/companies/micro-typing-systems-inc/3e72c0a5-173b-405a-b3d7-f6e8aac71430)
- [AlloSource](https://www.keypedia.com/companies/allosource/561511d2-2b9d-4a29-9565-deccb49a8455)
- [Paragon 28, Inc.](https://www.keypedia.com/companies/paragon-28-inc/71e9a57c-417a-4ed3-868f-57ec417b3c3d)
- [Bio-Rad Laboratories, Inc.](https://www.keypedia.com/companies/bio-rad-laboratories-inc/b3fd776e-6823-4ba3-87b0-f03cf4880139)
- [Scantibodies Laboratory, Inc.](https://www.keypedia.com/companies/scantibodies-laboratory-inc/87cffccc-0129-4ca1-b942-54c86ecde06f)
- [Lonza Walkersville, Inc.](https://www.keypedia.com/companies/lonza-walkersville-inc/5008199b-623e-432c-942c-db06b6333f53)
- [Etex Corporation](https://www.keypedia.com/companies/etex-corporation/0026be3f-54ba-49cd-8f79-b687c9d4353b)
- [Biomat USA, Inc](https://www.keypedia.com/companies/biomat-usa-inc/87c4c683-10f5-4773-a585-a44296a91b67)

## Related Officers

- [Investigator](https://www.keypedia.com/people/abby-l-mozeke-baker/32e2896f-b836-4752-862e-de98370b8cad)
